5,7-Dihydroxy-4-Methylcoumarin as a Functional Compound for Skin Pigmentation and Human Skin Safety

Area of Science:

• Biochemistry
• Dermatology
• Cosmetic Science

Background:

• Melanogenesis is crucial for skin pigmentation and protection.
• Disorders of pigmentation, like vitiligo, require effective therapeutic agents.
• Novel compounds are needed for cosmetic and therapeutic applications targeting skin pigmentation.

Purpose of the Study:

• To investigate the effects of 5,7-dihydroxy-4-methylcoumarin (5,7D-4MC) on melanogenesis in B16F10 murine melanoma cells.
• To evaluate the safety of 5,7D-4MC for potential use in cosmetics and treatments for pigmentation disorders.

Main Methods:

• Cytotoxicity assessed via MTT assay.
• Melanin content and tyrosinase activity measured at various concentrations.
• Western blot analysis for melanogenesis proteins (TYR, TRP-1, TRP-2, MITF) and signaling pathways (PKA/cAMP, GSK3β, PI3K/AKT).
• Human primary skin irritation test conducted.

Main Results:

• 5,7D-4MC promoted melanin production dose-dependently without affecting cell viability below 100 µM.
• Increased tyrosinase activity and melanogenic protein expression observed.
• PKA and GSK3β pathways were activated; PI3K/AKT pathway downregulated.
• Low skin irritation potential demonstrated at 50 µM and 100 µM.

Conclusions:

• 5,7D-4MC enhances melanogenesis and exhibits low skin irritation.
• It is a promising candidate for treating hypopigmentation disorders and as a functional cosmetic ingredient.
• Further research with human melanocytes and clinical trials is recommended.